141 related articles for article (PubMed ID: 2577204)
1. Carcinoma of the endometrium and hormonal receptors.
Satyaswaroop PG; Zaino RJ; Mortel R
Cancer Treat Res; 1989; 49():71-92. PubMed ID: 2577204
[No Abstract] [Full Text] [Related]
2. Changes in receptor status after treatment with tamoxifen in endometrial cancer.
Oriana S; Raspagliesi F; Duca PG; Coradini D; Di Re EM; Ragazzi D; Grillo T; Luciani L
Int J Biol Markers; 1988; 3(4):233-6. PubMed ID: 3235850
[TBL] [Abstract][Full Text] [Related]
3. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Thurzó L
Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245
[TBL] [Abstract][Full Text] [Related]
4. [Hormones in gynecologic oncology].
Maass H
Arch Gynecol Obstet; 1989; 245(1-4):466-73. PubMed ID: 2802734
[No Abstract] [Full Text] [Related]
5. Hormonal aspects of endometrial cancer.
Sutton G
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
[TBL] [Abstract][Full Text] [Related]
6. Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifen.
Luciani L; Oriana S; Spatti G; Secreto G; Recchione C; Grignoglio E; Andreola S; Coradini D; Ronchi E; Di Fronzo G
Tumori; 1984 Apr; 70(2):189-92. PubMed ID: 6428017
[TBL] [Abstract][Full Text] [Related]
7. Endocrine therapy of endometrial cancer.
Lentz SS
Cancer Treat Res; 1998; 94():89-106. PubMed ID: 9587684
[No Abstract] [Full Text] [Related]
8. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment.
Zaino RJ; Satyaswaroop PG; Mortel R
Arch Pathol Lab Med; 1984 Jul; 108(7):571-8. PubMed ID: 6547322
[TBL] [Abstract][Full Text] [Related]
9. Hormone steroid receptor variation after tamoxifen administration in endometrial adenocarcinoma from postmenopausal patients.
Di Fronzo G; Ronchi E; Cappelletti V; Luciani L; Coradini D; Oriana S; Miodini P; Andreola S
Cancer Detect Prev; 1986; 9(3-4):323-30. PubMed ID: 3742507
[TBL] [Abstract][Full Text] [Related]
10. [Hormonotherapy of carcinoma of the endometrium].
Sismondi P; Barengo R; Zola P; Giai M; De Fabiani E
Minerva Ginecol; 1986 Oct; 38(10):815-23. PubMed ID: 3808413
[No Abstract] [Full Text] [Related]
11. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
[TBL] [Abstract][Full Text] [Related]
12. [Significance of the determination of estrogen and progesterone receptors in trophoblast diseases].
Cseh I; Szepesi J; Walentin S; Szabó T; Dravucz S; Szalay J; Gati I
Zentralbl Gynakol; 1990; 112(3):151-9. PubMed ID: 2336890
[TBL] [Abstract][Full Text] [Related]
13. [Hormone dependence and steroid receptors in adenocarcinomas of the endometrium].
Lellouche D; Gairard B; Renaud R
Rev Fr Gynecol Obstet; 1987 May; 82(5):325-9. PubMed ID: 3602807
[TBL] [Abstract][Full Text] [Related]
14. Déjà vu for breast cancer two?
Stearns V; Davidson NE
J Natl Cancer Inst; 2004 Apr; 96(7):497-9. PubMed ID: 15069104
[No Abstract] [Full Text] [Related]
15. Nude mouse system in the study of tumor biology, treatment strategies and progesterone receptor physiology in human endometrial carcinoma.
Satyaswaroop PG; Zaino R; Clarke CL; Mortel R
J Steroid Biochem; 1987; 27(1-3):431-8. PubMed ID: 2961935
[TBL] [Abstract][Full Text] [Related]
16. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
17. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer].
Semilgazov VF; Manikhas AG; Semiglazov VV; Bozhok AA; Dashian GA; Ivanov VG; Paltuev RM; Vasil'ev AG; Shchedrin DE; Ermachenkova AM; Nikitina IV; Pen'kov KD; Bessonov AA; Tabagua TT; Kolar'kova VV
Vopr Onkol; 2011; 57(5):567-77. PubMed ID: 22238925
[No Abstract] [Full Text] [Related]
19. [Immunohistochemical detection of progesterone receptors in primary breast cancer and lymph node metastases].
Müller-Holzner E; Zeimet AG; Daxenbichler G; Marth C; Müller LC; Dapunt O
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():234-5. PubMed ID: 8118287
[No Abstract] [Full Text] [Related]
20. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
Stelzer P; Staab HJ; Kömpf J
Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
